EU regulators have delayed a decision to approve Novavax’s variant-tailored COVID-19 vaccine.

The European Medicines Agency (EMA) , which was due to approve the updated jab last Friday, instead requested more information.

#COVID19 #Novavax @auscovid19

Source: https://www.ft.com/content/2e10b2ab-7d0c-48a3-b49b-8de8dc302c6d

EU delays approval of Novavax’s revised Covid jab

US biotech has been struggling to overcome fall in demand for coronavirus jabs

Financial Times
@DenisCOVIDinfoguy @auscovid19 shoot there's a paywall. Any idea what they were wanting more information about ?